Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Profit & Loss 
Valuation 
Analyst Note 
Balance Sheet 
Cash Flow 
Financial Ratio 
Qtr. Results 
News 
About
Dolphin Medical Services Ltd (526504)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 526504 NSE: Hospital & Healthcare Services | Small Cap | Dolphin Medical Serv Share Price
₹8.67 0.00 (0.00%)
As on 06-Jul'26 16:59
Dolphin Medical Services Ltd (526504)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 526504 NSE: Hospital & Healthcare Services | Small Cap | Dolphin Medical Serv Share Price
₹8.67 0.00 (0.00%)
As on 06-Jul'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹13 Cr.
Current Price
₹8.7
52-Week Low / High
₹2 / 10
TTM EPS
₹0
TTM Sales
₹0.8 Cr.
Book Value per Share
₹6.7
P/E Ratio
311.71
Industry PE
93.9
Price to Book (P/B)
1.30
Higher than its 5-year historical median
Price to Sales (P/S)
17.46
Higher than its 5-year historical median
EV/EBITDA
86.59
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
-0.34%
Underperforms industry median
Return on Capital Employed (ROCE)
-0.18%
Underperforms industry median
Return on Assets (ROA)
-0.28%
Operating Profit Margin
0.8%
Net Profit Margin
-4.34%
Gross Profit Margin
4.2%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
14.71%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
26.44%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹-5 Cr.
Equity
₹15.1 Cr.
Face Value
₹10
All Time Low / High
₹0.39 / 28.40
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Dolphin Medical Services Ltd a good quality company?
Dolphin Medical Services Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Dolphin Medical Services Ltd performance compare with that of its Peers?
Revenue growth of Dolphin Medical Services Ltd vs industry peers?
Dolphin Medical Services Ltd revenue CAGR is 34.08%, compared to the industry median CAGR of 1.38%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Dolphin Medical Services Ltd?
Promoters hold 26.44% of the Dolphin Medical Services Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Dolphin Medical Services Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 25.2% based on the current price.
10 Year X-Ray : Login to view analysis.
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dolphin Medical Services Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -0.1% | -1.4% | -1.6% | -5.4% | -2.1% | -2% | -1.5% | -1% | -0.8% | -0.2% | - |
| Value Creation Index ⓘ | -1.0 | -1.1 | -1.1 | -1.4 | -1.2 | -1.1 | -1.1 | -1.1 | -1.1 | -1.0 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0.6 | 0.4 | 0.2 | 0.1 | 0.2 | 0.5 | 0.5 | 0.6 | 0.7 | 0.8 | 1 |
| Sales YoY Gr. | - | -38.6% | -57.1% | -60% | 200% | 161.1% | 10.6% | 17.3% | 11.5% | 14.7% | - |
| Adj EPS ⓘ | -0 | -0.1 | -0.2 | -0.3 | -0.3 | 2.4 | -0.1 | -0.1 | -0.1 | -0 | 0 |
| YoY Gr. | - | NA | NA | NA | NA | NA | -105.1% | NA | NA | NA | - |
| BVPS (₹) ⓘ | 8.5 | 8.3 | 8.1 | 7.4 | 7.2 | 7 | 6.8 | 6.7 | 6.7 | 6.7 | 6.7 |
| Adj Net Profit ⓘ | -0.1 | -0.2 | -0.3 | -0.5 | -0.4 | 3.6 | -0.2 | -0.1 | -0.1 | -0 | 0 |
| Cash Flow from Ops. ⓘ | -0.1 | -0.1 | -0 | 0 | -0.1 | 0.3 | -0.1 | -0.1 | -0.1 | -0.1 | - |
| Debt/CF from Ops. ⓘ | -67 | -114 | -2600.6 | 335.4 | -47.7 | 2.2 | -6.9 | -10.9 | -17.8 | -14.5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 3.6% | 34.1% | 14.5% | 14.7% | ||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||
| BVPSⓘ | -2.6% | -1.4% | -0.8% | -0.3% | ||||
| Share Price | 27.9% | 18.1% | 82.4% | 278.6% | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -0.4 | -1.6 | -2.4 | -4.4 | -3.5 | 33.3 | -1.8 | -1.2 | -1 | -0.3 | 0.5 |
| Op. Profit Mgn % ⓘ | 30.5 | 5.2 | -52.8 | -229.3 | -188.1 | -54.7 | -26.8 | -13.3 | -11.2 | 0.8 | 16.6 |
| Net Profit Mgn % ⓘ | -8.2 | -58.7 | -194.5 | -864.8 | -211.4 | 749.9 | -36 | -20.4 | -15.3 | -4.3 | 6 |
| Debt to Equity ⓘ | 0.6 | 0.7 | 0.7 | 0.6 | 0.6 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Working Cap Days ⓘ | 2,961 | 5,066 | 11,848 | 29,872 | 9,661 | 3,697 | 3,358 | 2,856 | 2,574 | 2,242 | 475 |
| Cash Conv. Cycle ⓘ | -0 | 6 | 9 | 11 | -0 | 1 | 1 | 2 | 3 | 4 | 286 |
Profit And Loss
(All Figures are in Crores.)| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.57 | 0.35 | 0.15 | 0.06 | 0.18 | 0.47 | 0.52 | 0.61 | 0.68 | 0.78 |
| Operating Expenses ⓘ + | 0.39 | 0.42 | 0.23 | 0.89 | 0.53 | 6.25 | 0.66 | 0.69 | 0.75 | 0.77 |
| Operating Profit ⓘ | 0.17 | -0.07 | -0.08 | -0.83 | -0.34 | -5.77 | -0.14 | -0.08 | -0.08 | 0.01 |
| Operating Profit Margin (%) | 30.5% | -19.7% | -52.8% | -1,386.0% | -188.0% | -1,220.3% | -26.8% | -13.3% | -11.2% | 0.8% |
| Other Income ⓘ + | 0.15 | 0.11 | 0.09 | 0.06 | 0.05 | 5.55 | 0.04 | 0.04 | 0.04 | 0.04 |
| Interest ⓘ | 0.06 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Depreciation ⓘ | 0.34 | 0.33 | 0.33 | 0.24 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 |
| Profit Before Tax ⓘ | -0.07 | -0.30 | -0.33 | -1.03 | -0.36 | -0.30 | -0.18 | -0.12 | -0.10 | -0.03 |
| Tax ⓘ | -0.02 | -0.03 | -0.04 | -0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0 |
| Profit After Tax | -0.05 | -0.27 | -0.30 | -1.01 | -0.39 | -0.31 | -0.19 | -0.12 | -0.10 | -0.03 |
| PAT Margin (%) | -8.2% | -76.1% | -194.0% | -1,674.5% | -211.0% | -66.0% | -36.0% | -20.4% | -15.3% | -4.3% |
| Adjusted EPS (₹) | -0.0 | -0.2 | -0.2 | -0.7 | -0.3 | -0.2 | -0.1 | -0.1 | -0.1 | -0.0 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Valuation of Dolphin Medical Serv - Standalone
Analyst's Notes
No data found!
Balance Sheet
(All Figures are in Crores.)| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 12.76 | 12.49 | 12.19 | 11.19 | 10.80 | 10.49 | 10.30 | 10.18 | 10.07 | 10.04 | |
| Debt + | 8.16 | 8.21 | 8.21 | 6.22 | 6.37 | 0.61 | 0.68 | 0.76 | 0.80 | 0.87 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Others Liabilities ⓘ | 0.68 | 0.65 | 0.61 | 0.58 | 0.71 | 1.23 | 1.25 | 1.24 | 1.26 | 1.17 | |
| Total Liabilities ⓘ | 21.60 | 21.35 | 21.01 | 17.99 | 17.88 | 12.33 | 12.23 | 12.17 | 12.13 | 12.08 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 10.36 | 10.03 | 9.70 | 6.79 | 6.74 | 3 | 2.94 | 2.87 | 2.83 | 2.76 | |
| CWIP ⓘ | 5.93 | 5.93 | 5.93 | 5.93 | 5.93 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | |
| Investments ⓘ | 0.52 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | |
| Inventories | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | |
| Trade Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash Equivalents | 0.01 | 0.01 | 0.01 | 0 | 0.01 | 0.04 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Others Assets ⓘ | 4.77 | 4.97 | 4.96 | 4.86 | 4.79 | 4.79 | 4.78 | 4.78 | 4.78 | 4.78 | |
| Total Assets ⓘ | 21.60 | 21.35 | 21.01 | 17.99 | 17.88 | 12.33 | 12.23 | 12.17 | 12.13 | 12.08 | |
Cash Flow
(All Figures are in Crores.)| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | -0.12 | -0.07 | -0 | 0.02 | -0.13 | 0.27 | -0.10 | -0.07 | -0.05 | -0.06 |
| Cash Flow From Investing Activity ⓘ + | 0.01 | 0.03 | 0 | 1.97 | -0.01 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow From Financing Activity ⓘ + | 0.11 | 0.05 | 0 | -1.99 | 0.15 | -0.25 | 0.07 | 0.07 | 0.05 | 0.06 |
| Net Cash Flow ⓘ | 0 | 0 | -0 | -0 | 0.01 | 0.03 | -0.02 | 0 | 0 | 0 |
Financial Ratio
| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | -0.36 | -2.12 | -2.41 | -8.6 | -3.5 | -2.93 | -1.8 | -1.22 | -1.03 | -0.34 |
| ROCE (%) | -0.06 | -1.43 | -1.57 | -5.38 | -2.07 | -2.01 | -1.5 | -0.98 | -0.79 | -0.18 |
| Asset Turnover Ratio | 0.03 | 0.02 | 0.01 | 0 | 0.01 | 0.03 | 0.04 | 0.05 | 0.06 | 0.06 |
| PAT to CFO Conversion(x) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Days | ||||||||||
| Receivable Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 4.80 | 6.60 | 10.60 | 0 | 0.70 | 0.70 | 1.40 | 1.90 | 3 | 3.90 |
| Payable Days | 17.40 | 6.40 | 17.10 | 19.60 | 5.10 | 0 | 0 | 0 | 0 | 0 |
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Dolphin Medical Services Ltd FAQs
The current trading price of Dolphin Medical Serv on 06-Jul-2026 16:59 is ₹8.67.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 05-Jul-2026 the market cap of Dolphin Medical Serv stood at ₹13.09 Cr
The latest P/E ratio of Dolphin Medical Serv as of 05-Jul-2026 is 311.7.
The latest P/B ratio of Dolphin Medical Serv as of 05-Jul-2026 is 1.30.
The 52-week high of Dolphin Medical Serv is ₹9.57 and the 52-week low is ₹1.98.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dolphin Medical Serv is ₹0.75 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dolphin Medical Services Ltd is a below average quality company.
The key valuation ratios of Dolphin Medical Services Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Dolphin Medical Services Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Dolphin Medical Services Ltd
Dolphin Medical Services Ltd. is an organization promoted by the doctors of the region. The chief promoters are Dr. M S S Koteswara Rao, an eminent physician and former Minister for health in Andhra Pradesh and Dr. G V Mohan Prasad, a radiologist cum ENT specialist who is also the Managing Director of the company. Dolphin was founded with a lofty ideal of providing quality medical services to improve the quality of life of the people through better health, in the last decade of the the 20th century by renowned medical technologists.
The company provides comprehensive Diagnostic Services since 1994, with a range of tests covering radiology and imaging, biochemistry, pathology and microbiology, etc., to the people of the coastal region of Andhra Pradesh.
The maiden venture of the group started at Visakhapatnam providing medical diagnostic services ranging from simple laboratory test to the complex whole body CT scanning under one roof thus saving the time and energy of the patients and assuring them accurate and prompt services.
Later, the group extended its activities to Vijayawada, a commercial, educational and medical centre of the coastal Andhra Pradesh and established a diagnostic centre with the most sophisticated and state-of-the-art equipment.The group turned a new leaf in providing diagnostic services in the medical field. Subsequently, the group opened an eye-care laser centre, the first of its kind unit in the entire coastal Andhra Pradesh. The eye-care laser centre is equipped with the ultra-modern laser equipment to provide readily available and highly reliable services to the patients of ophthalmic problems.
The company was able to withstand the tough competition in the market and still enhance the profitability of the company. The present status of the company is that the it is debt free and is profit making for the past three years with the profits increasing year after year. In addition it has also the eye care division called the “Dolphin Nethralaya†which is a comprehensive eye care and laser and research centre.The company has also ventured in to IT and biotechnology and Herbal sectors but attained only limited progress in these sectors due to some inherent constraints.
Services offered by the company:
- Dolphin Medical Services
- Dolphin Nethralaya
- Dolphin Electronic Solutions and Technologies(D.E.S.T)
- Dolphin Biotech Health Foods & Herbals
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
